See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2014

RETRO-HF

Presenter: Amit N. Patel

January 22, 2014

Presentation

Causes of Short-term Readmission After PCI

Presenter: J.H. Wasfy

January 22, 2014

Presentation Cell Therapy 2014

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Presenter: Philippe Henon

January 22, 2014

Presentation Cell Therapy 2014

Clinical Trials in Peripheral Arterial Disease

Presenter: Keith L. March

January 22, 2014

Presentation Cell Therapy 2014

Safety and Feasibility Trial of Adipose Derived Regenerative Cells in Treatment of Chronic Myocardial Ischemia (ATHENA)

Presenter: Emerson C. Perin

January 22, 2014

Presentation Cell Therapy 2014

HGF for Critical Limb Ischemia

Presenter: Emerson C. Perin

January 22, 2014

Presentation Cell Therapy 2014

Gene Modified EPCs for STEMI

Presenter: Michael Kutryk

January 22, 2014

Presentation Cell Therapy 2014

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Presenter: Micha? Tendera

January 22, 2014

Presentation Cell Therapy 2014

Cytokine-based peripheral blood stem cell therapy: MAGIC Cell-5-combicytokine trial

Presenter: Hyo-Soo Kim

January 22, 2014

Presentation Cell Therapy 2014

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

Presenter: Joseph C. Wu

January 22, 2014

Advertisement

Slides

RETRO-HF

Causes of Short-term Readmission After PCI

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Clinical Trials in Peripheral Arterial Disease

Safety and Feasibility Trial of Adipose Derived Regenerative Cells in Treatment of Chronic Myocardial Ischemia (ATHENA)

HGF for Critical Limb Ischemia

Gene Modified EPCs for STEMI

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Cytokine-based peripheral blood stem cell therapy: MAGIC Cell-5-combicytokine trial

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content